{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T03:23:32Z","timestamp":1769829812734,"version":"3.49.0"},"reference-count":90,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,11,8]]},"DOI":"10.7759\/cureus.19363","type":"journal-article","created":{"date-parts":[[2021,11,8]],"date-time":"2021-11-08T17:15:28Z","timestamp":1636391728000},"source":"Crossref","is-referenced-by-count":10,"title":["Management of Steroid-Resistant Nephrotic Syndrome in Children"],"prefix":"10.7759","author":[{"given":"Sanjana","family":"Sachdeva","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Syeda","family":"Khan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristian","family":"Davalos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chaithanya","family":"Avanthika","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sharan","family":"Jhaveri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Athira","family":"Babu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Patterson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdullah J","family":"Yamani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","unstructured":"Kdigo. Glomerular diseases (GD). (2021). Accessed. September 23, 2021: https:\/\/kdigo.org\/guidelines\/gd\/."},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2016.00039","article-title":"Ethnic differences in childhood nephrotic syndrome","volume":"4","author":"Chanchlani R","year":"2016","unstructured":"Chanchlani R, Parekh RS. Ethnic differences in childhood nephrotic syndrome. Front Pediatr. 2016, 4:39. 10.3389\/fped.2016.00039","journal-title":"Front Pediatr"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1007\/s004670100021","article-title":"Time trends and ethnic patterns of childhood nephrotic syndrome in Yorkshire, UK","volume":"16","author":"McKinney PA","year":"2001","unstructured":"McKinney PA, Feltbower RG, Brocklebank JT, Fitzpatrick MM. Time trends and ethnic patterns of childhood nephrotic syndrome in Yorkshire, UK. Pediatr Nephrol. 2001, 16:1040-4. 10.1007\/s004670100021","journal-title":"Pediatr Nephrol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1080\/20469047.2017.1374003","article-title":"Nephrotic syndrome in infants and children: pathophysiology and management","volume":"37","author":"Downie ML","year":"2017","unstructured":"Downie ML, Gallibois C, Parekh RS, Noone DG. Nephrotic syndrome in infants and children: pathophysiology and management. Paediatr Int Child Health. 2017, 37:248-58. 10.1080\/20469047.2017.1374003","journal-title":"Paediatr Int Child Health"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1007\/s00467-010-1495-0","article-title":"Hereditary nephrotic syndrome: a systematic approach for genetic testing and a review of associated podocyte gene mutations","volume":"25","author":"Benoit G","year":"2010","unstructured":"Benoit G, Machuca E, Antignac C. Hereditary nephrotic syndrome: a systematic approach for genetic testing and a review of associated podocyte gene mutations. Pediatr Nephrol. 2010, 25:1621-32. 10.1007\/s00467-010-1495-0","journal-title":"Pediatr Nephrol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1007\/s00467-009-1138-5","article-title":"Long-term outcome of idiopathic steroid-resistant nephrotic syndrome: a multicenter study","volume":"24","author":"Mekahli D","year":"2009","unstructured":"Mekahli D, Liutkus A, Ranchin B, et al.. Long-term outcome of idiopathic steroid-resistant nephrotic syndrome: a multicenter study. Pediatr Nephrol. 2009, 24:1525-32. 10.1007\/s00467-009-1138-5","journal-title":"Pediatr Nephrol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2014.00226","article-title":"Genes and podocytes - new insights into mechanisms of podocytopathy","volume":"5","author":"Bierzynska A","year":"2014","unstructured":"Bierzynska A, Soderquest K, Koziell A. Genes and podocytes - new insights into mechanisms of podocytopathy. Front Endocrinol (Lausanne). 2014, 5:226. 10.3389\/fendo.2014.00226","journal-title":"Front Endocrinol (Lausanne)"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2013111155","article-title":"Heterogeneous genetic alterations in sporadic nephrotic syndrome associate with resistance to immunosuppression","volume":"26","author":"Giglio S","year":"2015","unstructured":"Giglio S, Provenzano A, Mazzinghi B, et al.. Heterogeneous genetic alterations in sporadic nephrotic syndrome associate with resistance to immunosuppression. J Am Soc Nephrol. 2015, 26:230-6. 10.1681\/ASN.2013111155","journal-title":"J Am Soc Nephrol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1754.2007.01077.x","article-title":"Idiopathic nephrotic syndrome in New Zealand children, demographic, clinical features, initial management and outcome after twelve-month follow-up: results of a three-year national surveillance study","volume":"43","author":"Wong W","year":"2007","unstructured":"Wong W. Idiopathic nephrotic syndrome in New Zealand children, demographic, clinical features, initial management and outcome after twelve-month follow-up: results of a three-year national surveillance study. J Paediatr Child Health. 2007, 43:337-41. 10.1111\/j.1440-1754.2007.01077.x","journal-title":"J Paediatr Child Health"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2003.08.010","article-title":"Is there really an increase in non-minimal change nephrotic syndrome in children?","volume":"42","author":"Filler G","year":"2003","unstructured":"Filler G, Young E, Geier P, Carpenter B, Drukker A, Feber J. Is there really an increase in non-minimal change nephrotic syndrome in children?. Am J Kidney Dis. 2003, 42:1107-13. 10.1053\/j.ajkd.2003.08.010","journal-title":"Am J Kidney Dis"},{"key":"ref11","article-title":"North American Pediatric Renal Trials and Collaborative Studies 2008 Annual Report: Renal Transplantation, Dialysis, Chronic Renal Insufficiency","author":"Martz K","unstructured":"Martz K, Stablein D. North American Pediatric Renal Trials and Collaborative Studies 2008 Annual Report: Renal Transplantation, Dialysis, Chronic Renal Insufficiency. NAPRTCS, Woburn, MA;"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2014050489","article-title":"A single-gene cause in 29.5% of cases of steroid-resistant nephrotic syndrome","volume":"26","author":"Sadowski CE","year":"2015","unstructured":"Sadowski CE, Lovric S, Ashraf S, et al.. A single-gene cause in 29.5% of cases of steroid-resistant nephrotic syndrome. J Am Soc Nephrol. 2015, 26:1279-89. 10.1681\/ASN.2014050489","journal-title":"J Am Soc Nephrol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1007\/s00467-017-3590-y","article-title":"Spectrum of mutations in Chinese children with steroid-resistant nephrotic syndrome","volume":"32","author":"Wang F","year":"2017","unstructured":"Wang F, Zhang Y, Mao J, et al.. Spectrum of mutations in Chinese children with steroid-resistant nephrotic syndrome. Pediatr Nephrol. 2017, 32:1181-92. 10.1007\/s00467-017-3590-y","journal-title":"Pediatr Nephrol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2016101121","article-title":"Long-term outcome of steroid-resistant nephrotic syndrome in children","volume":"28","author":"Trautmann A","year":"2017","unstructured":"Trautmann A, Schnaidt S, Lipska-Zi\u0119tkiewicz BS, et al.. Long-term outcome of steroid-resistant nephrotic syndrome in children. J Am Soc Nephrol. 2017, 28:3055-65. 10.1681\/ASN.2016101121","journal-title":"J Am Soc Nephrol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2013080852","article-title":"Initial steroid sensitivity in children with steroid-resistant nephrotic syndrome predicts post-transplant recurrence","volume":"25","author":"Ding WY","year":"2014","unstructured":"Ding WY, Koziell A, McCarthy HJ, et al.. Initial steroid sensitivity in children with steroid-resistant nephrotic syndrome predicts post-transplant recurrence. J Am Soc Nephrol. 2014, 25:1342-8. 10.1681\/ASN.2013080852","journal-title":"J Am Soc Nephrol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/s0022-3476(81)80760-3","article-title":"The primary nephrotic syndrome in children. Identification of patients with minimal change nephrotic syndrome from initial response to prednisone. A report of the international study of kidney disease in children","volume":"98","year":"1981","unstructured":"The primary nephrotic syndrome in children. Identification of patients with minimal change nephrotic syndrome from initial response to prednisone. A report of the international study of kidney disease in children. J Pediatr. 1981, 98.561-564. 10.1016\/s0022-3476(81)80760-3","journal-title":"J Pediatr"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.2010.05817.x","article-title":"Hereditary kidney diseases: highlighting the importance of classical Mendelian phenotypes","volume":"1214","author":"Benoit G","year":"2010","unstructured":"Benoit G, Machuca E, Heidet L, Antignac C. Hereditary kidney diseases: highlighting the importance of classical Mendelian phenotypes. Ann N Y Acad Sci. 2010, 1214:83-98. 10.1111\/j.1749-6632.2010.05817.x","journal-title":"Ann N Y Acad Sci"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/s2352-4642(18)30283-9","article-title":"Management of steroid-resistant nephrotic syndrome in children and adolescents","volume":"2","author":"Tullus K","year":"2018","unstructured":"Tullus K, Webb H, Bagga A. Management of steroid-resistant nephrotic syndrome in children and adolescents. Lancet Child Adolesc Health. 2018, 2:880-90. 10.1016\/s2352-4642(18)30283-9","journal-title":"Lancet Child Adolesc Health"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1038\/sj.ki.5002222","article-title":"The spectrum of podocytopathies: a unifying view of glomerular diseases","volume":"71","author":"Wiggins RC","year":"2007","unstructured":"Wiggins RC. The spectrum of podocytopathies: a unifying view of glomerular diseases. Kidney Int. 2007, 71:1205-14. 10.1038\/sj.ki.5002222","journal-title":"Kidney Int"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1172\/JCI79504","article-title":"KANK deficiency leads to podocyte dysfunction and nephrotic syndrome","volume":"125","author":"Gee HY","year":"2015","unstructured":"Gee HY, Zhang F, Ashraf S, et al.. KANK deficiency leads to podocyte dysfunction and nephrotic syndrome. J Clin Invest. 2015, 125:2375-84. 10.1172\/JCI79504","journal-title":"J Clin Invest"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.V212s258","article-title":"Recurrence of focal segmental glomerulosclerosis posttransplantation: a special report of the North American Pediatric Renal Transplant Cooperative Study","volume":"2","author":"Tejani A","year":"1992","unstructured":"Tejani A, Stablein DH. Recurrence of focal segmental glomerulosclerosis posttransplantation: a special report of the North American Pediatric Renal Transplant Cooperative Study. J Am Soc Nephrol. 1992, 2:S258-63. 10.1681\/ASN.V212s258","journal-title":"J Am Soc Nephrol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2007.03.005","article-title":"TRPC6 and FSGS: the latest TRP channelopathy","volume":"1772","author":"Mukerji N","year":"2007","unstructured":"Mukerji N, Damodaran TV, Winn MP. TRPC6 and FSGS: the latest TRP channelopathy. Biochim Biophys Acta. 2007, 1772:859-68. 10.1016\/j.bbadis.2007.03.005","journal-title":"Biochim Biophys Acta"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1038\/ng1918","article-title":"Positional cloning uncovers mutations in PLCE1 responsible for a nephrotic syndrome variant that may be reversible","volume":"38","author":"Hinkes B","year":"2006","unstructured":"Hinkes B, Wiggins RC, Gbadegesin R, et al.. Positional cloning uncovers mutations in PLCE1 responsible for a nephrotic syndrome variant that may be reversible. Nat Genet. 2006, 38:1397-405. 10.1038\/ng1918","journal-title":"Nat Genet"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfn712","article-title":"CD2AP mutations are associated with sporadic nephrotic syndrome and focal segmental glomerulosclerosis (FSGS)","volume":"24","author":"Gigante M","year":"2009","unstructured":"Gigante M, Pontrelli P, Montemurno E, et al.. CD2AP mutations are associated with sporadic nephrotic syndrome and focal segmental glomerulosclerosis (FSGS). Nephrol Dial Transplant. 2009, 24:1858-64. 10.1093\/ndt\/gfn712","journal-title":"Nephrol Dial Transplant"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.2147\/PHMT.S100803","article-title":"Steroid-resistant nephrotic syndrome: past and current perspectives","volume":"8","author":"Nourbakhsh N","year":"2017","unstructured":"Nourbakhsh N, Mak RH. Steroid-resistant nephrotic syndrome: past and current perspectives. Pediatric Health Med Ther. 2017, 8:29-37. 10.2147\/PHMT.S100803","journal-title":"Pediatric Health Med Ther"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1159\/000350163","article-title":"Mechanisms of glucocorticoid resistance in idiopathic nephrotic syndrome","volume":"37","author":"Che R","year":"2013","unstructured":"Che R, Zhang A. Mechanisms of glucocorticoid resistance in idiopathic nephrotic syndrome. Kidney Blood Press Res. 2013, 37:360-78. 10.1159\/000350163","journal-title":"Kidney Blood Press Res"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2016.10.013","article-title":"Genomic and clinical profiling of a national nephrotic syndrome cohort advocates a precision medicine approach to disease management","volume":"91","author":"Bierzynska A","year":"2017","unstructured":"Bierzynska A, McCarthy HJ, Soderquest K, et al.. Genomic and clinical profiling of a national nephrotic syndrome cohort advocates a precision medicine approach to disease management. Kidney Int. 2017, 91:937-47. 10.1016\/j.kint.2016.10.013","journal-title":"Kidney Int"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1007\/s00467-017-3838-6","article-title":"Genetic testing in steroid-resistant nephrotic syndrome: why, who, when and how?","volume":"34","author":"Preston R","year":"2019","unstructured":"Preston R, Stuart HM, Lennon R. Genetic testing in steroid-resistant nephrotic syndrome: why, who, when and how?. Pediatr Nephrol. 2019, 34:195-210. 10.1007\/s00467-017-3838-6","journal-title":"Pediatr Nephrol"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1016\/s1097-2765(00)80057-x","article-title":"Positionally cloned gene for a novel glomerular protein--nephrin--is mutated in congenital nephrotic syndrome","volume":"1","author":"Kestil\u00e4 M","year":"1998","unstructured":"Kestil\u00e4 M, Lenkkeri U, M\u00e4nnikk\u00f6 M, et al.. Positionally cloned gene for a novel glomerular protein--nephrin--is mutated in congenital nephrotic syndrome. Mol Cell. 1998, 1:575-82. 10.1016\/s1097-2765(00)80057-x","journal-title":"Mol Cell"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/11.4.379","article-title":"Genotype\/phenotype correlations of NPHS1 and NPHS2 mutations in nephrotic syndrome advocate a functional inter-relationship in glomerular filtration","volume":"11","author":"Koziell A","year":"2002","unstructured":"Koziell A, Grech V, Hussain S, Lee G, Lenkkeri U, Tryggvason K, Scambler P. Genotype\/phenotype correlations of NPHS1 and NPHS2 mutations in nephrotic syndrome advocate a functional inter-relationship in glomerular filtration. Hum Mol Genet. 2002, 11:379-88. 10.1093\/hmg\/11.4.379","journal-title":"Hum Mol Genet"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.V132388","article-title":"Novel mutations in NPHS2 detected in both familial and sporadic steroid-resistant nephrotic syndrome","volume":"13","author":"Karle SM","year":"2002","unstructured":"Karle SM, Uetz B, Ronner V, Glaeser L, Hildebrandt F, Fuchshuber A. Novel mutations in NPHS2 detected in both familial and sporadic steroid-resistant nephrotic syndrome. J Am Soc Nephrol. 2002, 13:388-93. 10.1681\/ASN.V132388","journal-title":"J Am Soc Nephrol"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1111\/j.1523-1755.2005.00202.x","article-title":"Analysis of NPHS1, NPHS2, ACTN4, and WT1 in Japanese patients with congenital nephrotic syndrome","volume":"67","author":"Sako M","year":"2005","unstructured":"Sako M, Nakanishi K, Obana M, et al.. Analysis of NPHS1, NPHS2, ACTN4, and WT1 in Japanese patients with congenital nephrotic syndrome. Kidney Int. 2005, 67:1248-55. 10.1111\/j.1523-1755.2005.00202.x","journal-title":"Kidney Int"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1172\/JCI16242","article-title":"NPHS2 mutations in late-onset focal segmental glomerulosclerosis: R229Q is a common disease-associated allele","volume":"110","author":"Tsukaguchi H","year":"2002","unstructured":"Tsukaguchi H, Sudhakar A, Le TC, et al.. NPHS2 mutations in late-onset focal segmental glomerulosclerosis: R229Q is a common disease-associated allele. J Clin Invest. 2002, 110:1659-66. 10.1172\/JCI16242","journal-title":"J Clin Invest"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra052131","article-title":"Hereditary proteinuria syndromes and mechanisms of proteinuria","volume":"354","author":"Tryggvason K","year":"2006","unstructured":"Tryggvason K, Patrakka J, Wartiovaara J. Hereditary proteinuria syndromes and mechanisms of proteinuria. N Engl J Med. 2006, 354:1387-401. 10.1056\/NEJMra052131","journal-title":"N Engl J Med"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1111\/j.1523-1755.2004.00479.x","article-title":"NPHS2 R229Q functional variant is associated with microalbuminuria in the general population","volume":"65","author":"Pereira AC","year":"2004","unstructured":"Pereira AC, Pereira AB, Mota GF, et al.. NPHS2 R229Q functional variant is associated with microalbuminuria in the general population. Kidney Int. 2004, 65:1026-30. 10.1111\/j.1523-1755.2004.00479.x","journal-title":"Kidney Int"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1038\/ki.2013.519","article-title":"Genotype-phenotype associations in WT1 glomerulopathy","volume":"85","author":"Lipska BS","year":"2014","unstructured":"Lipska BS, Ranchin B, Iatropoulos P, et al.. Genotype-phenotype associations in WT1 glomerulopathy. Kidney Int. 2014, 85:1169-78. 10.1038\/ki.2013.519","journal-title":"Kidney Int"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfp229","article-title":"TRPC6 mutational analysis in a large cohort of patients with focal segmental glomerulosclerosis","volume":"24","author":"Sant\u00edn S","year":"2009","unstructured":"Sant\u00edn S, Ars E, Rossetti S, et al.. TRPC6 mutational analysis in a large cohort of patients with focal segmental glomerulosclerosis. Nephrol Dial Transplant. 2009, 24:3089-96. 10.1093\/ndt\/gfp229","journal-title":"Nephrol Dial Transplant"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfr202","article-title":"TRPC6 gene variants in Turkish children with steroid-resistant nephrotic syndrome","volume":"27","author":"Mir S","year":"2012","unstructured":"Mir S, Yavascan O, Berdeli A, Sozeri B. TRPC6 gene variants in Turkish children with steroid-resistant nephrotic syndrome. Nephrol Dial Transplant. 2012, 27:205-9. 10.1093\/ndt\/gfr202","journal-title":"Nephrol Dial Transplant"},{"key":"ref39","article-title":"TRPC6 gene promoter polymorphisms in steroid resistant nephrotic syndrome children","volume":"4","author":"Mahesh Kumar KB","year":"2015","unstructured":"Mahesh Kumar KB, Prabha S, Ramprasad E, Bhaskar LV, Soundararajan P.  TRPC6 gene promoter polymorphisms in steroid resistant nephrotic syndrome children. J Nephropharmacol. 2015, 4:52-6.","journal-title":"J Nephropharmacol"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.07830910","article-title":"TRPC6 mutations in children with steroid-resistant nephrotic syndrome and atypical phenotype","volume":"6","author":"Gigante M","year":"2011","unstructured":"Gigante M, Caridi G, Montemurno E, et al.. TRPC6 mutations in children with steroid-resistant nephrotic syndrome and atypical phenotype. Clin J Am Soc Nephrol. 2011, 6:1626-34. 10.2215\/CJN.07830910","journal-title":"Clin J Am Soc Nephrol"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.02040507","article-title":"A case of familial kidney disease","volume":"2","author":"Pollak MR","year":"2007","unstructured":"Pollak MR, Alexander MP, Henderson JM. A case of familial kidney disease. Clin J Am Soc Nephrol. 2007, 2:1367-74. 10.2215\/CJN.02040507","journal-title":"Clin J Am Soc Nephrol"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1038\/73456","article-title":"Mutations in ACTN4, encoding alpha-actinin-4, cause familial focal segmental glomerulosclerosis","volume":"24","author":"Kaplan JM","year":"2000","unstructured":"Kaplan JM, Kim SH, North KN, et al.. Mutations in ACTN4, encoding alpha-actinin-4, cause familial focal segmental glomerulosclerosis. Nat Genet. 2000, 24:251-6. 10.1038\/73456","journal-title":"Nat Genet"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1186\/s13578-015-0036-8","article-title":"The role of alpha-actinin-4 in human kidney disease","volume":"5","author":"Feng D","year":"2015","unstructured":"Feng D, DuMontier C, Pollak MR. The role of alpha-actinin-4 in human kidney disease. Cell Biosci. 2015, 5:44. 10.1186\/s13578-015-0036-8","journal-title":"Cell Biosci"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1038\/sj.ki.5001679","article-title":"Recessive missense mutations in LAMB2 expand the clinical spectrum of LAMB2-associated disorders","volume":"70","author":"Hasselbacher K","year":"2006","unstructured":"Hasselbacher K, Wiggins RC, Matejas V, et al.. Recessive missense mutations in LAMB2 expand the clinical spectrum of LAMB2-associated disorders. Kidney Int. 2006, 70:1008-12. 10.1038\/sj.ki.5001679","journal-title":"Kidney Int"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1172\/JCI45693","article-title":"COQ6 mutations in human patients produce nephrotic syndrome with sensorineural deafness","volume":"121","author":"Heeringa SF","year":"2011","unstructured":"Heeringa SF, Chernin G, Chaki M, et al.. COQ6 mutations in human patients produce nephrotic syndrome with sensorineural deafness. J Clin Invest. 2011, 121:2013-24. 10.1172\/JCI45693","journal-title":"J Clin Invest"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1086\/510023","article-title":"Leigh syndrome with nephropathy and CoQ10 deficiency due to decaprenyl diphosphate synthase subunit 2 (PDSS2) mutations","volume":"79","author":"L\u00f3pez LC","year":"2006","unstructured":"L\u00f3pez LC, Schuelke M, Quinzii CM, et al.. Leigh syndrome with nephropathy and CoQ10 deficiency due to decaprenyl diphosphate synthase subunit 2 (PDSS2) mutations. Am J Hum Genet. 2006, 79:1125-9. 10.1086\/510023","journal-title":"Am J Hum Genet"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1172\/JCI69000","article-title":"ADCK4 mutations promote steroid-resistant nephrotic syndrome through CoQ10 biosynthesis disruption","volume":"123","author":"Ashraf S","year":"2013","unstructured":"Ashraf S, Gee HY, Woerner S, et al.. ADCK4 mutations promote steroid-resistant nephrotic syndrome through CoQ10 biosynthesis disruption. J Clin Invest. 2013, 123:5179-89. 10.1172\/JCI69000","journal-title":"J Clin Invest"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc0800582","article-title":"Early coenzyme Q10 supplementation in primary coenzyme Q10 deficiency","volume":"358","author":"Montini G","year":"2008","unstructured":"Montini G, Malaventura C, Salviati L. Early coenzyme Q10 supplementation in primary coenzyme Q10 deficiency. N Engl J Med. 2008, 358:2849-50. 10.1056\/NEJMc0800582","journal-title":"N Engl J Med"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.1097\/MNH.0b013e328341164a","article-title":"Angiotensin-converting enzyme 2 is a key modulator of the renin-angiotensin system in cardiovascular and renal disease","volume":"20","author":"Tikellis C","year":"2011","unstructured":"Tikellis C, Bernardi S, Burns WC. Angiotensin-converting enzyme 2 is a key modulator of the renin-angiotensin system in cardiovascular and renal disease. Curr Opin Nephrol Hypertens. 2011, 20:62-8. 10.1097\/MNH.0b013e328341164a","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2377-8-4","article-title":"Angiotensin-converting enzyme gene insertion\/deletion polymorphism in migraine patients","volume":"8","author":"Tronvik E","year":"2008","unstructured":"Tronvik E, Stovner LJ, Bovim G, White LR, Gladwin AJ, Owen K, Schrader H. Angiotensin-converting enzyme gene insertion\/deletion polymorphism in migraine patients. BMC Neurol. 2008, 8:4. 10.1186\/1471-2377-8-4","journal-title":"BMC Neurol"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.1159\/000097367","article-title":"Association of angiotensin I-converting enzyme gene insertion\/deletion polymorphism and IgA nephropathy: a meta-analysis","volume":"26","author":"Yong D","year":"2006","unstructured":"Yong D, Qing WQ, Hua L, Kan JJ, Xi CJ, Jin QQ, Chao SH. Association of angiotensin I-converting enzyme gene insertion\/deletion polymorphism and IgA nephropathy: a meta-analysis. Am J Nephrol. 2006, 26:511-8. 10.1159\/000097367","journal-title":"Am J Nephrol"},{"key":"ref52","doi-asserted-by":"publisher","DOI":"10.1177\/1470320309359021","article-title":"Effect of angiotensin-converting enzyme gene insertion\/deletion polymorphism on steroid resistance in Egyptian children with idiopathic nephrotic syndrome","volume":"11","author":"Saber-Ayad M","year":"2010","unstructured":"Saber-Ayad M, Sabry S, Abdel-Latif I, Nabil H, El-Azm SA, Abdel-Shafy S. Effect of angiotensin-converting enzyme gene insertion\/deletion polymorphism on steroid resistance in Egyptian children with idiopathic nephrotic syndrome. J Renin Angiotensin Aldosterone Syst. 2010, 11:111-8. 10.1177\/1470320309359021","journal-title":"J Renin Angiotensin Aldosterone Syst"},{"key":"ref53","doi-asserted-by":"publisher","DOI":"10.1172\/JCI69134","article-title":"ARHGDIA mutations cause nephrotic syndrome via defective RHO GTPase signaling","volume":"123","author":"Gee HY","year":"2013","unstructured":"Gee HY, Saisawat P, Ashraf S, et al.. ARHGDIA mutations cause nephrotic syndrome via defective RHO GTPase signaling. J Clin Invest. 2013, 123:3243-53. 10.1172\/JCI69134","journal-title":"J Clin Invest"},{"key":"ref54","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2018.00200","article-title":"Exploring the clinical and genetic spectrum of steroid resistant nephrotic syndrome: the PodoNet Registry","volume":"6","author":"Trautmann A","year":"2018","unstructured":"Trautmann A, Lipska-Zi\u0119tkiewicz BS, Schaefer F. Exploring the clinical and genetic spectrum of steroid resistant nephrotic syndrome: the PodoNet Registry. Front Pediatr. 2018, 6:200. 10.3389\/fped.2018.00200","journal-title":"Front Pediatr"},{"key":"ref55","doi-asserted-by":"publisher","DOI":"10.1007\/s00467-020-04519-1","article-title":"IPNA clinical practice recommendations for the diagnosis and management of children with steroid-resistant nephrotic syndrome","volume":"35","author":"Trautmann A","year":"2020","unstructured":"Trautmann A, Vivarelli M, Samuel S, et al.. IPNA clinical practice recommendations for the diagnosis and management of children with steroid-resistant nephrotic syndrome. Pediatr Nephrol. 2020, 35:1529-61. 10.1007\/s00467-020-04519-1","journal-title":"Pediatr Nephrol"},{"key":"ref56","doi-asserted-by":"publisher","DOI":"10.1007\/s00467-012-2304-8","article-title":"Treatment of steroid-resistant nephrotic syndrome in children: new guidelines from KDIGO","volume":"28","author":"Lombel RM","year":"2013","unstructured":"Lombel RM, Hodson EM, Gipson DS. Treatment of steroid-resistant nephrotic syndrome in children: new guidelines from KDIGO. Pediatr Nephrol. 2013, 28:409-14. 10.1007\/s00467-012-2304-8","journal-title":"Pediatr Nephrol"},{"key":"ref57","doi-asserted-by":"publisher","DOI":"10.1007\/s00467-006-0138-y","article-title":"Predictive factors of chronic kidney disease in primary focal segmental glomerulosclerosis","volume":"21","author":"Abrantes MM","year":"2006","unstructured":"Abrantes MM, Cardoso LS, Lima EM, Penido Silva JM, Diniz JS, Bambirra EA, Oliveira EA. Predictive factors of chronic kidney disease in primary focal segmental glomerulosclerosis. Pediatr Nephrol. 2006, 21:1003-12. 10.1007\/s00467-006-0138-y","journal-title":"Pediatr Nephrol"},{"key":"ref58","doi-asserted-by":"publisher","DOI":"10.1038\/ki.2011.195","article-title":"Clinical trial of focal segmental glomerulosclerosis in children and young adults","volume":"80","author":"Gipson DS","year":"2011","unstructured":"Gipson DS, Trachtman H, Kaskel FJ, et al.. Clinical trial of focal segmental glomerulosclerosis in children and young adults. Kidney Int. 2011, 80:868-78. 10.1038\/ki.2011.195","journal-title":"Kidney Int"},{"key":"ref59","doi-asserted-by":"publisher","DOI":"10.1007\/s00467-010-1471-8","article-title":"Long-term outcome of children with steroid-resistant nephrotic syndrome treated with tacrolimus","volume":"25","author":"Roberti I","year":"2010","unstructured":"Roberti I, Vyas S. Long-term outcome of children with steroid-resistant nephrotic syndrome treated with tacrolimus. Pediatr Nephrol. 2010, 25:1117-24. 10.1007\/s00467-010-1471-8","journal-title":"Pediatr Nephrol"},{"key":"ref60","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2018010036","article-title":"Early proteinuria lowering by angiotensin-converting enzyme inhibition predicts renal survival in children with CKD","volume":"29","author":"van den Belt SM","year":"2018","unstructured":"van den Belt SM, Heerspink HJ, Gracchi V, de Zeeuw D, W\u00fchl E, Schaefer F. Early proteinuria lowering by angiotensin-converting enzyme inhibition predicts renal survival in children with CKD. J Am Soc Nephrol. 2018, 29:2225-33. 10.1681\/ASN.2018010036","journal-title":"J Am Soc Nephrol"},{"key":"ref61","doi-asserted-by":"publisher","DOI":"10.1007\/s00467-006-0096-4","article-title":"Effect of fosinopril in children with steroid-resistant idiopathic nephrotic syndrome","volume":"21","author":"Yi Z","year":"2006","unstructured":"Yi Z, Li Z, Wu XC, He QN, Dang XQ, He XJ. Effect of fosinopril in children with steroid-resistant idiopathic nephrotic syndrome. Pediatr Nephrol. 2006, 21:967-72. 10.1007\/s00467-006-0096-4","journal-title":"Pediatr Nephrol"},{"key":"ref62","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2018.06.010","article-title":"Use of renin-angiotensin system blockade in advanced CKD: an NKF-KDOQI controversies report","volume":"72","author":"Weir MR","year":"2018","unstructured":"Weir MR, Lakkis JI, Jaar B, Rocco MV, Choi MJ, Kramer HJ, Ku E. Use of renin-angiotensin system blockade in advanced CKD: an NKF-KDOQI controversies report. Am J Kidney Dis. 2018, 72:873-84. 10.1053\/j.ajkd.2018.06.010","journal-title":"Am J Kidney Dis"},{"key":"ref63","doi-asserted-by":"publisher","DOI":"10.1007\/s00467-009-1264-0","article-title":"Cyclosporine and steroid therapy in children with steroid-resistant nephrotic syndrome","volume":"24","author":"Hamasaki Y","year":"2009","unstructured":"Hamasaki Y, Yoshikawa N, Hattori S, et al.. Cyclosporine and steroid therapy in children with steroid-resistant nephrotic syndrome. Pediatr Nephrol. 2009, 24:2177-85. 10.1007\/s00467-009-1264-0","journal-title":"Pediatr Nephrol"},{"key":"ref64","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfm092","article-title":"Steroid-resistant idiopathic childhood nephrosis: overdiagnosed and undertreated","volume":"22","author":"Ehrich JH","year":"2007","unstructured":"Ehrich JH, Geerlings C, Zivicnjak M, Franke D, Geerlings H, Gellermann J. Steroid-resistant idiopathic childhood nephrosis: overdiagnosed and undertreated. Nephrol Dial Transplant. 2007, 22:2183-93. 10.1093\/ndt\/gfm092","journal-title":"Nephrol Dial Transplant"},{"key":"ref65","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.V5101820","article-title":"Aggressive, long-term cyclosporine therapy for steroid-resistant focal segmental glomerulosclerosis","volume":"5","author":"Ingulli E","year":"1995","unstructured":"Ingulli E, Singh A, Baqi N, Ahmad H, Moazami S, Tejani A. Aggressive, long-term cyclosporine therapy for steroid-resistant focal segmental glomerulosclerosis. J Am Soc Nephrol. 1995, 5:1820-5. 10.1681\/ASN.V5101820","journal-title":"J Am Soc Nephrol"},{"key":"ref66","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2017.01.019","article-title":"Mycophenolate mofetil is inferior to tacrolimus in\u00a0sustaining remission in children with idiopathic\u00a0steroid-resistant nephrotic syndrome","volume":"92","author":"Sinha A","year":"2017","unstructured":"Sinha A, Gupta A, Kalaivani M, Hari P, Dinda AK, Bagga A. Mycophenolate mofetil is inferior to tacrolimus in\u00a0sustaining remission in children with idiopathic\u00a0steroid-resistant nephrotic syndrome. Kidney Int. 2017, 92:248-57. 10.1016\/j.kint.2017.01.019","journal-title":"Kidney Int"},{"key":"ref67","doi-asserted-by":"publisher","DOI":"10.1007\/s00467-017-3641-4","article-title":"Nephrotoxicity in children with frequently relapsing nephrotic syndrome receiving long-term cyclosporine treatment","volume":"32","author":"Hamasaki Y","year":"2017","unstructured":"Hamasaki Y, Komaki F, Ishikura K, et al.. Nephrotoxicity in children with frequently relapsing nephrotic syndrome receiving long-term cyclosporine treatment. Pediatr Nephrol. 2017, 32:1383-90. 10.1007\/s00467-017-3641-4","journal-title":"Pediatr Nephrol"},{"key":"ref68","doi-asserted-by":"publisher","DOI":"10.1136\/jclinpath-2011-200005","article-title":"Predictive factors for ciclosporin-associated nephrotoxicity in children with minimal change nephrotic syndrome","volume":"64","author":"Kim JH","year":"2011","unstructured":"Kim JH, Park SJ, Yoon SJ, et al.. Predictive factors for ciclosporin-associated nephrotoxicity in children with minimal change nephrotic syndrome. J Clin Pathol. 2011, 64:516-9. 10.1136\/jclinpath-2011-200005","journal-title":"J Clin Pathol"},{"key":"ref69","doi-asserted-by":"publisher","DOI":"10.1038\/sj.ki.5002553","article-title":"Cyclosporin in idiopathic glomerular disease associated with the nephrotic syndrome: workshop recommendations","volume":"72","author":"Cattran DC","year":"2007","unstructured":"Cattran DC, Alexopoulos E, Heering P, et al.. Cyclosporin in idiopathic glomerular disease associated with the nephrotic syndrome: workshop recommendations. Kidney Int. 2007, 72:1429-47. 10.1038\/sj.ki.5002553","journal-title":"Kidney Int"},{"key":"ref70","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.01190210","article-title":"Immunosuppression and renal outcome in congenital and pediatric steroid-resistant nephrotic syndrome","volume":"5","author":"B\u00fcscher AK","year":"2010","unstructured":"B\u00fcscher AK, Kranz B, B\u00fcscher R, et al.. Immunosuppression and renal outcome in congenital and pediatric steroid-resistant nephrotic syndrome. Clin J Am Soc Nephrol. 2010, 5:2075-84. 10.2215\/CJN.01190210","journal-title":"Clin J Am Soc Nephrol"},{"key":"ref71","doi-asserted-by":"publisher","DOI":"10.1093\/ckj\/sfw047","article-title":"Chronic kidney disease in children","volume":"9","author":"Becherucci F","year":"2016","unstructured":"Becherucci F, Roperto RM, Materassi M, Romagnani P. Chronic kidney disease in children. Clin Kidney J. 2016, 9:583-91. 10.1093\/ckj\/sfw047","journal-title":"Clin Kidney J"},{"key":"ref72","doi-asserted-by":"publisher","DOI":"10.4103\/0971-4065.114462","article-title":"Basics of kidney biopsy: a nephrologist's perspective","volume":"23","author":"Agarwal SK","year":"2013","unstructured":"Agarwal SK, Sethi S, Dinda AK. Basics of kidney biopsy: a nephrologist's perspective. Indian J Nephrol. 2013, 23:243-52. 10.4103\/0971-4065.114462","journal-title":"Indian J Nephrol"},{"key":"ref73","doi-asserted-by":"publisher","DOI":"10.1007\/s00467-005-2084-5","article-title":"Experience of renal biopsy in children with nephrotic syndrome","volume":"21","author":"Nammalwar BR","year":"2006","unstructured":"Nammalwar BR, Vijayakumar M, Prahlad N. Experience of renal biopsy in children with nephrotic syndrome. Pediatr Nephrol. 2006, 21:286-8. 10.1007\/s00467-005-2084-5","journal-title":"Pediatr Nephrol"},{"key":"ref74","doi-asserted-by":"publisher","DOI":"10.1007\/s00467-017-3687-3","article-title":"Indications for kidney biopsy in idiopathic childhood nephrotic syndrome","volume":"32","author":"Alshami A","year":"2017","unstructured":"Alshami A, Roshan A, Catapang M, et al.. Indications for kidney biopsy in idiopathic childhood nephrotic syndrome. Pediatr Nephrol. 2017, 32:1897-905. 10.1007\/s00467-017-3687-3","journal-title":"Pediatr Nephrol"},{"key":"ref75","article-title":"Percutaneous kidney biopsy, analysis of 26 years: complication rate and risk factors; comment [Article in Spanish]","volume":"52","author":"Gonz\u00e1lez-Michaca L","year":"2000","unstructured":"Gonz\u00e1lez-Michaca L, Chew-Wong A, Soltero L, Gamba G, Correa-Rotter R. Percutaneous kidney biopsy, analysis of 26 years: complication rate and risk factors; comment [Article in Spanish]. Rev Invest Clin. 2000, 52:125-31.","journal-title":"Rev Invest Clin"},{"key":"ref76","article-title":"Complications of percutaneous renal biopsy: a review of 37 years' experience","volume":"38","author":"Parrish AE","year":"1992","unstructured":"Parrish AE. Complications of percutaneous renal biopsy: a review of 37 years' experience. Clin Nephrol. 1992, 38:135-41.","journal-title":"Clin Nephrol"},{"key":"ref77","doi-asserted-by":"publisher","DOI":"10.1097\/01.asn.0000102472.37947.14","article-title":"Timing of complications in percutaneous renal biopsy","volume":"15","author":"Whittier WL","year":"2004","unstructured":"Whittier WL, Korbet SM. Timing of complications in percutaneous renal biopsy. J Am Soc Nephrol. 2004, 15:142-7. 10.1097\/01.asn.0000102472.37947.14","journal-title":"J Am Soc Nephrol"},{"key":"ref78","article-title":"Treatment of steroid-resistant pediatric nephrotic syndrome","volume":"54","author":"Kang HG","year":"2011","unstructured":"Kang HG. Treatment of steroid-resistant pediatric nephrotic syndrome. Korean J Pediatr. 2011, 54:317-21.","journal-title":"Korean J Pediatr"},{"key":"ref79","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/6832971","article-title":"Recurrence and treatment after renal transplantation in children with FSGS","volume":"2016","author":"Kang HG","year":"2016","unstructured":"Kang HG, Ha IS, Cheong HI. Recurrence and treatment after renal transplantation in children with FSGS. Biomed Res Int. 2016, 2016:6832971. 10.1155\/2016\/6832971","journal-title":"Biomed Res Int"},{"key":"ref80","doi-asserted-by":"publisher","DOI":"10.1007\/s00467-018-3994-3","article-title":"Recurrence of nephrotic syndrome following kidney transplantation is associated with initial native kidney biopsy findings","volume":"33","author":"Pelletier JH","year":"2018","unstructured":"Pelletier JH, Kumar KR, Engen R, et al.. Recurrence of nephrotic syndrome following kidney transplantation is associated with initial native kidney biopsy findings. Pediatr Nephrol. 2018, 33:1773-80. 10.1007\/s00467-018-3994-3","journal-title":"Pediatr Nephrol"},{"key":"ref81","doi-asserted-by":"publisher","DOI":"10.1007\/s40620-019-00660-9","article-title":"Post-transplant recurrence of steroid resistant nephrotic syndrome in children: the Italian experience","volume":"33","author":"Morello W","year":"2020","unstructured":"Morello W, Puvinathan S, Puccio G, et al.. Post-transplant recurrence of steroid resistant nephrotic syndrome in children: the Italian experience. J Nephrol. 2020, 33:849-57. 10.1007\/s40620-019-00660-9","journal-title":"J Nephrol"},{"key":"ref82","doi-asserted-by":"publisher","DOI":"10.1007\/s10157-016-1313-5","article-title":"Rituximab for nephrotic syndrome in children","volume":"21","author":"Iijima K","year":"2017","unstructured":"Iijima K, Sako M, Nozu K. Rituximab for nephrotic syndrome in children. Clin Exp Nephrol. 2017, 21:193-202. 10.1007\/s10157-016-1313-5","journal-title":"Clin Exp Nephrol"},{"key":"ref83","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-12-129262","article-title":"Analysis of regulatory T-cell changes in patients with idiopathic thrombocytopenic purpura receiving B cell-depleting therapy with rituximab","volume":"112","author":"Stasi R","year":"2008","unstructured":"Stasi R, Cooper N, Del Poeta G, Stipa E, Laura Evangelista M, Abruzzese E, Amadori S. Analysis of regulatory T-cell changes in patients with idiopathic thrombocytopenic purpura receiving B cell-depleting therapy with rituximab. Blood. 2008, 112:1147-50. 10.1182\/blood-2007-12-129262","journal-title":"Blood"},{"key":"ref84","doi-asserted-by":"publisher","DOI":"10.1007\/s11255-008-9393-0","article-title":"Remission of steroid-resistant nephrotic syndrome due to focal and segmental glomerulosclerosis using rituximab","volume":"40","author":"Suri M","year":"2008","unstructured":"Suri M, Tran K, Sharma AP, Filler G, Grimmer J. Remission of steroid-resistant nephrotic syndrome due to focal and segmental glomerulosclerosis using rituximab. Int Urol Nephrol. 2008, 40:807-10. 10.1007\/s11255-008-9393-0","journal-title":"Int Urol Nephrol"},{"key":"ref85","doi-asserted-by":"publisher","DOI":"10.1097\/TP.0b013e3181aed9d7","article-title":"Use of rituximab in focal glomerulosclerosis relapses after renal transplantation","volume":"88","author":"Dello Strologo L","year":"2009","unstructured":"Dello Strologo L, Guzzo I, Laurenzi C, et al.. Use of rituximab in focal glomerulosclerosis relapses after renal transplantation. Transplantation. 2009, 88:417-20. 10.1097\/TP.0b013e3181aed9d7","journal-title":"Transplantation"},{"key":"ref86","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc1308488","article-title":"Ofatumumab for rituximab-resistant nephrotic syndrome","volume":"370","author":"Basu B","year":"2014","unstructured":"Basu B. Ofatumumab for rituximab-resistant nephrotic syndrome. N Engl J Med. 2014, 370:1268-70. 10.1056\/NEJMc1308488","journal-title":"N Engl J Med"},{"key":"ref87","doi-asserted-by":"publisher","DOI":"10.1007\/s00467-020-04481-y","article-title":"Low-dose ofatumumab for multidrug-resistant nephrotic syndrome in children: a randomized placebo-controlled trial","volume":"35","author":"Ravani P","year":"2020","unstructured":"Ravani P, Pisani I, Bodria M, Caridi G, Degl'Innocenti ML, Ghiggeri GM. Low-dose ofatumumab for multidrug-resistant nephrotic syndrome in children: a randomized placebo-controlled trial. Pediatr Nephrol. 2020, 35:997-1003. 10.1007\/s00467-020-04481-y","journal-title":"Pediatr Nephrol"},{"key":"ref88","article-title":"Developing therapeutic 'arrows' with the precision of William Tell: the time has come for targeted therapies in kidney disease","volume":"24","author":"Mundel P","year":"2015","unstructured":"Mundel P, Greka A. Developing therapeutic 'arrows' with the precision of William Tell: the time has come for targeted therapies in kidney disease. Curr Opin Nephrol Hypertens. 2015, 24:388-92.","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"ref89","doi-asserted-by":"publisher","DOI":"10.5414\/CN109290","article-title":"Abatacept efficacy in steroid-resistant minimal-change disease revealed by the speed of proteinuria reduction after the start of abatacept","volume":"89","author":"Dado D","year":"2018","unstructured":"Dado D, Parikh S, Ayoub I, Rovin B, Nadasdy T, Hebert L. Abatacept efficacy in steroid-resistant minimal-change disease revealed by the speed of proteinuria reduction after the start of abatacept. Clin Nephrol. 2018, 89:376-80. 10.5414\/CN109290","journal-title":"Clin Nephrol"},{"key":"ref90","doi-asserted-by":"publisher","DOI":"10.24953\/turkjped.2020.04.018","article-title":"A partial response to abatacept in a patient with steroid resistant focal segmental glomerulosclerosis","volume":"62","author":"Soyalt\u0131n E","year":"2020","unstructured":"Soyalt\u0131n E, Demir BK, Alparslan C, \u00c7amlar SA, Alaygut D, Yava\u015fcan \u00d6, Mutluba\u015f F. A partial response to abatacept in a patient with steroid resistant focal segmental glomerulosclerosis. Turk J Pediatr. 2020, 62:663-7. 10.24953\/turkjped.2020.04.018","journal-title":"Turk J Pediatr"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/75221-management-of-steroid-resistant-nephrotic-syndrome-in-children","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:33:35Z","timestamp":1707507215000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/75221-management-of-steroid-resistant-nephrotic-syndrome-in-children"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,8]]},"references-count":90,"URL":"https:\/\/doi.org\/10.7759\/cureus.19363","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11,8]]}}}